40 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
40 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
40 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
40 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
80 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
80 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
40 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.
40 nm spherical gold nanoparticles for covalent conjugation. The carboxyl surface can be conjugated to free amines in antibodies and proteins, allowing for greater stability, sensitivity, and control over particle-antibody loading.